Prostate cancer is among the most common cancers in American men. According to the American Cancer Society, more than 186,000 new cases are diagnosed each year.
Penn urologists are leaders in robotic prostatectomy, a minimally-invasive, high-tech treatment for prostate cancer. Since 2005, we have been using robotic-assisted technology to completely remove the prostate - and hopefully eradicate the cancer. We routinely perform more of these operations on a weekly basis than any health system on the East Coast.
During a robotic prostatectomy, six tiny incisions are made in the patient’s abdomen, and laparoscopic instruments are carefully inserted and attached to the robot. In experienced hands, this technique offers similar outcomes to traditional prostate cancer surgery; however, it ultimately causes less pain and less blood loss.
Nearly all patients go home the day after surgery. Patients can generally resume all activities by three weeks after surgery.